Obtaining patient phenotypes in SARS-CoV-2 pneumonia, and their association with clinical severity and mortality
2024

Identifying Patient Groups in SARS-CoV-2 Pneumonia

Sample size: 1548 publication Evidence: high

Author Information

Author(s): García-García Fernando, Lee Dae-Jin, Nieves-Ermecheo Mónica, Bronte Olaia, España Pedro Pablo, Quintana José María, Menéndez Rosario, Torres Antoni, Ruiz Iturriaga Luis Alberto, Urrutia Isabel

Primary Institution: Basque Center for Applied Mathematics (BCAM), Bilbao, Basque Country Spain

Hypothesis

Can distinct clinical phenotypes among hospitalized patients with SARS-CoV-2 pneumonia be identified and associated with clinical outcomes?

Conclusion

Three distinct patient phenotypes were identified, each showing strong associations with clinical severity and mortality in SARS-CoV-2 pneumonia.

Supporting Evidence

  • Phenotype A was associated with lower severity and mortality.
  • Phenotype B showed moderate risk for severity and mortality.
  • Phenotype C had the highest risk for severe outcomes.

Takeaway

Doctors found three different types of patients with COVID-19 pneumonia, and each type had different chances of getting worse or dying.

Methodology

Multicentric observational, prospective, longitudinal cohort study using machine learning clustering to identify phenotypes.

Potential Biases

Potential inclusion bias due to hospital admission policies during the pandemic.

Limitations

The study's observational design may introduce bias, and it only includes baseline data without considering disease dynamics or treatment responses.

Participant Demographics

Adult patients (≥ 18 years old) admitted for SARS-CoV-2 pneumonia.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/s41479-024-00132-0

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication